ASCO Direct™ Highlights Conference​


Stephanie Graff, MD, FACP
Stephanie Graff, MD, FACPLifespan Cancer Institute
Dr. Stephanie Graff, MD, FACP is the Director of Breast Oncology at Lifespan Cancer Institute at the Legorreta Cancer Center at Brown University in Providence, Rhode Island. Dr. Graff serves as co-lead of the Breast Cancer Translational Research Disease Working Group at Brown University and is an Associate Professor of Medicine at the Warren-Alpert School of Medicine.
Alex A. Adjei, MD, PhD, FACP, FASCO
Alex A. Adjei, MD, PhD, FACP, FASCOCleveland Clinic
Alex A. Adjei is Chairman of the Taussig Cancer Institute and the M. Frank Rudy and Margaret D. Rudy Distinguished Chair in Translational Cancer Research at Cleveland Clinic. He received the first American Society of Clinical Oncology Drug Development Research Professorship 2012-2017, in recognition of his mentorship and work in cancer drug development.
Ramaswamy Govindan, MD
Ramaswamy Govindan, MDWashington University
Dr. Ramaswamy Govindan is the Director of the Section of Medical Oncology and Associate Chief of the Division of Oncology at Washington University School of Medicine in St Louis. As a medical oncologist interested in thoracic malignancies, Dr. Govindan has led a number of institutional and multi- center phase II and III studies in lung cancer over the past decade.
Robin Zon, MD, FACP, FASCO
Robin Zon, MD, FACP, FASCOCincinnati Cancer Advisors
Dr. Zon currently practices as physician emeritus at Michiana Hematology Oncology in Mishawaka, Indiana, where she served as Past-President. She formerly served as Medical Director of Oncology Research at Memorial Hospital and NCI CCOP Associate and then Principal Investigator until 2013 for the Northern Indiana Cancer Research Consortium, the only NCI-designated Community Cancer Oncology Program in the state of Indiana.
Frank Anthony Greco, MD
Frank Anthony Greco, MDSarah Cannon Research Institute
Frank Anthony Greco MD was previously Professor of Medicine, Director of Medical Oncology at Vanderbilt and Director of the Vanderbilt University Cancer Center in Nashville Tennessee. In 1993 he was the co-founder of the Sarah Cannon Research Institute also located in Nashville Tennessee. His principal professional interest has been clinical cancer research with particular interest over the years in patients with cancers of unknown primary site (CUP), lung cancers and germ-cell tumors.
Mohamed Salem, MD
Mohamed Salem, MDLevine Cancer Institute
Mohamed Salem, MD is a Gastrointestinal oncologist at Levine Cancer Institute in Charlotte. Dr. Salem specializes in the treatment of GI malignancies—particularly colorectal cancer, pancreatic cancer—and state-of-the-art approaches for advanced malignancies. He also has a special interest in colon cancer in adolescents and young adults, precision medicine and immunotherapy and published extensively on those topics.
Lawrence H. Einhorn, MD
Lawrence H. Einhorn, MDIndiana University
Lawrence H. Einhorn, M.D., has been widely recognized for his success in medical oncology and in the development of a curative treatment for testis cancer, the most common cancer in young men. Dr. Einhorn pursued his undergraduate education at Indiana University Bloomington. He received his medical education at the University of Iowa, but returned to Indiana University for a residency in internal medicine and a portion of his fellowship in hematology/oncology. He joined the Indiana University faculty in 1973 and was named a distinguished professor of medicine in 1987.


Copyright 2021. All Rights Reserved

Session 2 Title Here

Language here and here and here and.

Session Description

Language here and here and here and here and here and here and here and. Language here and here and here and here and here and here and here and.